Signaling proteins are represented in tissue fluid/lymph from soft tissues of normal human legs at concentrations different from serum

Lymphatic Research and Biology

Volumn 11, Issue 4, 2013, Pages 203-210

  Zaleska, Marzanna ^a   Olszewski, Waldemar L ^a,b   Durlik, Marek ^a,b   Miller, Norman E ^c  

^a MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

^b CENTRAL CLINICAL HOSPITAL   (Poland)

^c MAGDALEN COLLEGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CYTOKINE; ENZYME; TISSUE ENZYME; UNCLASSIFIED DRUG;

ARTICLE; HUMAN; HUMAN TISSUE; LEG; LYMPH; LYMPHATIC DRAINAGE; LYMPHEDEMA; MALE; NORMAL HUMAN; PRIORITY JOURNAL; SERUM; SOFT TISSUE; TISSUE WATER;

CYTOKINES; HEALTHY VOLUNTEERS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LEG; LYMPH; LYMPHATIC VESSELS; MALE; MATRIX METALLOPROTEINASE 9; SERUM; SIGNAL TRANSDUCTION; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2;

EID: 84891114086     PISSN: 15396851     EISSN: 15578585     Source Type: Journal    
DOI: 10.1089/lrb.2013.0014     Document Type: Article

References (38)

1. OlszewskiWL, Engeset A, qukasiewicz H. Immunoglobulins, complement and lysozyme in leg lymph of normal men. Scand J Clin Lab Invest 1977;37:669-674. (Pubitemid 8387594)
2. Olszewski WL, Engeset A. Immune proteins, enzymes and electrolytes in human peripheral lymph. Lymphology 1978; 11:156-164. (Pubitemid 9076366)
3. Olszewski WL. Immune proteins, cell interactions and immunoregulatory hormones: Lymph versus blood. Lymphology 1987;20:239-243. (Pubitemid 18087352)
4. Olszewski WL, Loe K, Engeset A. Immune proteins and other biochemical constituents of peripheral lymph in patients with malignancy and postirradiation lymphedema. Lymphology 1992;25:166-171. (Pubitemid 23024635)
5. Olszewski WL, Jamal S, qukomska B, Manokaran G, Grzelak I. Immune proteins in peripheral tissue fluid-lymph in patients with filarial lymphedema of the lower limbs. Lymphology 1992;25:166-171. (Pubitemid 23024635)
6. Olszewski WL. Collection and physiological measurements of peripheral lymph and interstitial fluid in man. Lymphology 1977;10:137-145. (Pubitemid 8098558)
7. Olszewski WL, Grzelak I, Zió 1kowska A, Engeset A. Epidermal cell thymocyte activity factor/interleukin 1 (ETAF/IL)-like activity in lymph drained from normal human skin. Lymphology 1988;21:118-123.
8. Olszewski WL, Grzelak I, Ziolkowska A, Engeset A. Effect of local hyperthermia on lymph immune cells and lymphokines of normal human skin. J Surg Oncol 1989;11:109-116. (Pubitemid 19147467)
9. Olszewski WL, Pazdur J, Kubasiewicz E, Zaleska M, Cooke CJ, Miller NE. Lymph draining from foot joints in rheumatoid arthritis provides insight into local cytokine and chemokine production and transport to lymph nodes. Arthritis Rheum 2001;44:541-549. (Pubitemid 32234612)
10. Olszewski WL, Engeset A, Soko1owski J. Lymph flow and protein in the normal male leg during lying, getting up, and walking. Lymphology 1977;10:178-183. (Pubitemid 8232985)
11. Nanjee MN, Cooke CJ, Wong JS, Hamilton RL, Olszewski WL, Miller NE. Composition and ultrastructure of size subclasses of normal human peripheral lymph lipoproteins: quantification of cholesterol uptake by HDL in tissue fluids. J Lipid Res 2001;4:639-648. (Pubitemid 32367007)
12. Nanjee MN, Cooke CJ, Olszewski WL, Miller NE. Lipid and apolipoprotein concentrations in prenodal leg lymph of fasted humans. Associations with plasma concentrations in normal subjects, lipoprotein lipase deficiency, and LCAT deficiency. J Lipid Res 2000;41:1317-1327. (Pubitemid 30666897)
13. Blanton RA, Kupper TS, McDougall JK, Dower S. Regulation of interleukin 1 and its receptor in human keratinocytes. Proc Natl Acad Sci 1989;86:1273-1277. (Pubitemid 19061528)
14. Heinrich PC, Behrmann I, Haan S, Hermanns HM, Mü ller-Newen G, Schaper F. Principles of interleukin-6-type cytokine signalling and its regulation. Biochem J 2003;374: 1-20. (Pubitemid 37046923)
15. Utgaard JO, Jahnsen FL, Bakka A, Brandtzaeg P, Haraldsen G. Rapid secretion of prestored interleukin 8 from Weibel-Palade bodies of microvascular endothelial cells. J Exp Med 1998;188:1751-1756. (Pubitemid 28516119)
16. Kaliń ski P, Hilkens CM, Snijders A, Snijdewint FG, Kapsenberg ML. IL-12-deficient dendritic cells, generated in the presence of prostaglandin E2, promote type 2 cytokine production in maturing human naive T helper cells. J Immunol 1997;159:28-35.
17. Steel JC, Waldmann TA, Morris JC. Interleukin-15 biology and its therapeutic implications in cancer. Trends Pharmacol Sci 2012;33:35-41.
18. Bashir MM, Sharma MR, Werth VP. TNF-alpha production in the skin. Arch Dermatol Res 2009; 30: 87-91.
19. Dinarello CA. The interleukin-1 family: 10 years of discovery. FASEB J 1994;8:1314-1325.
20. Pestka S, Krause CD, Sarkar D, Walter MR, Shi Y, Fisher PB. Interleukin-10 and related cytokines and receptors. Annu Rev Immunol 2004;22:929-979. (Pubitemid 38680445)
21. Jiang CK, Magnaldo T, Ohtsuki M, Freedberg IM, Bernerd F, Blumenberg M. Epidermal growth factor and transforming growth factor alpha specifically induce the activation-and hyperproliferation-associated keratins 6 and 16. Proc Natl Acad Sci USA 1993;90:6786-6790. (Pubitemid 23207298)
22. Brennan AM, Mantzoros CS. Drug Insight: The role of leptin in human physiology and pathophysiology-Emerging clinical applications. Nat Clin Pract Endocrinol Metab 2006; 2:318-327. (Pubitemid 43885911)
23. D?́ez JJ, Iglesias P. The role of the novel adipocyte-derived hormone adiponectin in human disease. Eur J Endocrinol 2003;148:293-300. (Pubitemid 36410714)
24. Randolph GJ. Dendritic cell migration to lymph nodes: Cytokines, chemokines, and lipid mediators. Semin Immunol 2001;13:267-274. (Pubitemid 32744577)
25. Morales J, Homey B, Vicari AP, Hudak S, Oldham E, Hedrick J, Orozco R, Copeland NG, Jenkins NA, McEvoy LM, Zlotnik A. CTACK, a skin-associated chemokine that preferentially attracts skin-homing memory T cells. Proc Natl Acad Sci USA 1999;96:14470-14475. (Pubitemid 30000674)
26. Maurer M, von Stebut E. Macrophage inflammatory protein-1. Int J Biochem Cell Biol 2004;36:1882-1886. (Pubitemid 38760018)
27. Mancardi S,Vecile E, Dusetti N, Calvo E, Stanta G, Burrone OR, Dobrina A. Evidence of CXC, CC and C chemokine production by lymphatic endothelial cells. Immunology 2003;108:523-530. (Pubitemid 36469690)
28. Shin HY, Smith ML, Toy KJ, et al. VEGF-C mediates cyclic pressure-induced endothelial cell proliferation. Physiol Genomics 2002;11:245-251.
29. Rotolo S, Ceccarelli S, Romano F, Frati L, Marchese C, Angeloni A. Silencing of keratinocyte growth factor receptor restores 5-fluorouracil and tamoxifen efficacy on responsive cancer cells. PLoS ONE 2008;3:e2528.
30. Mann A, Breuhahn K, Schimacher P, Blessing M. Keratinocytederived granulocyte-macrophage colony stimulating factor accelerates wound healing: Stimulation of keratinocyte proliferation, granulation tissue formation, and vascularization. J Invest Dermatol 2001;117:1382-1390. (Pubitemid 34032763)
31. Schoenborn JR, Wilson CB. Regulation of interferon-gamma during innate and adaptive immune responses. Adv Immunol 2007;96:41-101. (Pubitemid 350018717)
32. Lindeman JH, Abdul-Hussien H, van Bockel JH, Wolterbeek R, Kleemann R. Clinical trial of doxycycline for matrix metalloproteinase-9 inhibition in patients with an abdominal aneurysm: Doxycycline selectively depletes aortic wall neutrophils and cytotoxic T cells. Circulation 2009;119:2209-2216.
33. Reichenstein M, Reich R, LeHoux JG, Hanukoglu I. ACTH induces TIMP-1 expression and inhibits collagenase in adrenal cortex cells. Mol Cell Endocrinol 2004;215:109-114. (Pubitemid 38333248)
34. Zucker S, Drews M, Conner C, Foda HD, DeClerck YA, Langley KE, BahouWF, Docherty AJ, Cao J. Tissue inhibitor of metalloproteinase-2 (TIMP-2) binds to the catalytic domain of the cell surface receptor, membrane type 1-matrix metalloproteinase 1 (MT1-MMP). J Biol Chem 1998;273:1216-1222. (Pubitemid 28049224)
35. Broudy VC. Stem cell factor and hematopoiesis. Blood 1997;90:1345-1364. (Pubitemid 27355406)
36. Ansel KM, Harris RB, Cyster JG. CXCL13 is required for B1 cell homing, natural antibody production, and body cavity immunity". Immunity 2002;6:67-76. (Pubitemid 34143217)
37. Chaitanya GV, Franks SE, Cromer W, et al. Differential cytokine responses in human and mouse lymphatic endothelial cells to cytokines in Vitro. Lymphat Res Biol 2010;8:155-164.
38. Fang C, Miguel MA, Avis I, Martinez A, Zudaire E, Cuttitta F. Non-peptide small molecule regulators of lymphangiogenesis. Lymphat Res Biol 2009;7:189-196.